New Nordic Healthbrands AB Reports Positive Q2 2025 Performance Amid Market Challenges
Sammanfattning
New Nordic Healthbrands AB's Q2 2025 results show a 1.5% increase in net sales and improved profitability. The company focuses on innovation and market expansion to drive future growth.New Nordic Healthbrands AB Reports Positive Q2 2025 Performance Amid Market Challenges
New Nordic Healthbrands AB (publ), a leading provider of dietary supplements and natural health products, has released its financial results for the second quarter of 2025, ending June 30. The company reported a 1.5% increase in net sales, reaching SEK 143.0 million, with a significant improvement in operating and net profit.
Key Performance Indicators (KPIs)
| KPI | Q2 2025 | Q2 2024 |
|---|---|---|
| Net Sales (SEK million) | 143.0 | 140.9 |
| Gross Margin (%) | 64.8 | 65.4 |
| Operating Profit (SEK million) | 3.8 | -1.9 |
| Net Profit (SEK million) | 2.1 | -4.5 |
| Earnings Per Share (SEK) | 0.34 | -0.72 |
| Cash Flow from Operations (SEK million) | 3.5 | 0 |
Year-Over-Year Comparison
| KPI | Change (%) |
|---|---|
| Net Sales | 1.5 |
| Gross Margin | -0.6 |
| Operating Profit | 300.0 |
| Net Profit | 146.7 |
| Earnings Per Share | 147.2 |
| Cash Flow from Operations | 350.0 |
Analysis and Outlook
The company's Q2 2025 performance highlights its resilience in the face of market challenges. The increase in net sales, despite a slight decline in gross margin, indicates strong demand for New Nordic's products. The significant improvement in operating and net profit reflects effective cost management and strategic investments in innovation and market expansion.
CEO Karl Kristian Bergman Jensen noted that revenue growth was primarily driven by strong sales performance of recently launched innovations, particularly in Europe and North America. The company plans to increase marketing investments and expand its distribution network in the second half of 2025 to capitalize on growth opportunities.
New Nordic remains focused on strengthening its position in existing markets while exploring new opportunities through reputable distributors. The company's long-term growth strategy emphasizes product innovation and expanding its product range to meet evolving consumer needs.
Conclusion
New Nordic Healthbrands AB's Q2 2025 results demonstrate a positive trajectory, with improved profitability and strategic growth initiatives. The company's focus on innovation and market expansion positions it well for continued success in the dietary supplement industry.
